…9.1%) and 90 days (62.5% vs 60.5%). However, patients with good milrinone tolerance had significantly better outcomes than those without …
Milrinone
This drug is selected. Its supporting articles are shown below.
Articles mentioning Milrinone
8 articles · page 1 of 1…ledge in post-PDA closure management and safety and efficacy of milrinone in preterm infants.Trial registration number NCT06679855.…
…l ischemia despite current endovascular and medical management. Milrinone is an effective phosphodiesterase-3 (PDE-3) inhibitor for vasod…
… first multicentre randomised study to evaluate the efficacy of intravenous milrinone in improving the neurological outcomes at 3 months in patients …
…irmed with carotid duplex. The patient was started on DAPT with aspirin, clopidogrel and subsequently underwent left ICA cervical segme…
…3 224 infusions were administered, with morphine, clonidine and milrinone representing 61%. Most of them (83.6%) were initiated in childr…
…creases and decreases in contractility parameters. For example, Milrinone (Phosphodiesterase-3 inhibitor) and Digoxin (Na +/K+ATPase inhi…
…nistered via the same line as PN (esomeprazole, chlorphenamine, milrinone, midazolam, rocuronium, furosemide and magnesium sulphate). No …